Amundi’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$222K Buy
+6,247
New +$189K ﹤0.01% 1948
2025
Q2
– Sell
-4,137
Closed -$79.4K – 1789
2025
Q1
$79.4K Buy
4,137
+4,111
+15,812% +$102K ﹤0.01% 1774
2024
Q4
$851 Buy
+26
New +$792 ﹤0.01% 2042
2022
Q1
– Sell
-2,350
Closed -$87K – 1657
2021
Q4
$87K Buy
2,350
+1,689
+256% +$88.3K ﹤0.01% 1584
2021
Q3
$44K Buy
+661
New +$46.5K ﹤0.01% 1535

Other funds holding CSTL

Amundi's CSTL Position: Q3 2026 in Review

Amundi opened a new position in Castle Biosciences (CSTL) in Q3 2026: 6,247 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #1948 among its holdings. This is a return to the name: Amundi previously reported a position in CSTL as recently as Q1 2025.

Amundi first reported a position in CSTL in Q3 2021 and has held it in 5 quarters since. 202 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.

  • Amundi held 6,247 shares of Castle Biosciences worth $222K as of Q3 2026.
  • Castle Biosciences was a new Amundi position in Q3 2026.
  • Castle Biosciences made up ﹤0.01% of Amundi's portfolio in Q3 2026, its #1948 holding.
  • Amundi first reported a position in Castle Biosciences in Q3 2021 and has held it in 5 quarters since.
  • 202 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.

Based on Amundi's 13F filing for Q3 2026, filed 6 Nov 2026.